Literature DB >> 11294728

Promoting quality through measurement of performance and response: prevention success stories.

C Richards1, T G Emori, G Peavy, R Gaynes.   

Abstract

Successful efforts to prevent health-care acquired infections occur daily in U.S. hospitals. However, few of these "success stories" are presented in the medical literature or discussed at professional meetings. Key components of successful prevention efforts include multidisciplinary teams, appropriate educational interventions, and data dissemination to clinical staff.

Mesh：

Year:  2001        PMID： 11294728      PMCID： PMC2631720          DOI： 10.3201/eid0702.010231

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  9 in total

1.  Feedback to nursing staff as an intervention to reduce catheter-associated urinary tract infections.

Authors:  A M Goetz; S Kedzuf; M Wagener; R R Muder
Journal:  Am J Infect Control       Date:  1999-10       Impact factor: 2.918

2.  Improving care through collaboration.

Authors:  C M Kilo
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

3.  The American health care system--the movement for improved quality in health care.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

Review 4.  Collaborating across organizational boundaries to improve the quality of care.

Authors:  P E Plsek
Journal:  Am J Infect Control       Date:  1997-04       Impact factor: 2.918

5.  The three faces of performance measurement: improvement, accountability, and research.

Authors:  L I Solberg; G Mosser; S McDonald
Journal:  Jt Comm J Qual Improv       Date:  1997-03

6.  Utilizing national nosocomial infection surveillance system data to improve urinary tract infection rates in three intensive-care units.

Authors:  D G Dumigan; C A Kohan; C R Reed; J F Jekel; M K Fikrig
Journal:  Clin Perform Qual Health Care       Date:  1998 Oct-Dec

7.  Harvesting knowledge from improvement.

Authors:  D M Berwick
Journal:  JAMA       Date:  1996-03-20       Impact factor: 56.272

8.  Improving hospital-acquired infection rates: the CDC experience.

Authors:  R P Gaynes; S Solomon
Journal:  Jt Comm J Qual Improv       Date:  1996-07

9.  The clinical experience of continuous quality improvement in the neonatal intensive care unit.

Authors:  D Bishop-Kurylo
Journal:  J Perinat Neonatal Nurs       Date:  1998-06       Impact factor: 1.638
  9 in total
  6 in total

1.  Using real time process measurements to reduce catheter related bloodstream infections in the intensive care unit.

Authors:  R J Wall; E W Ely; T A Elasy; R S Dittus; J Foss; K S Wilkerson; T Speroff
Journal:  Qual Saf Health Care       Date:  2005-08

2.  Population-based epidemiology of Staphylococcus aureus bloodstream infection: clonal complex 30 genotype is associated with mortality.

Authors:  A Blomfeldt; A N Eskesen; H V Aamot; T M Leegaard; J V Bjørnholt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

Review 3.  Urinary tract infections in the frail elderly: issues for diagnosis, treatment and prevention.

Authors:  Chesley L Richards
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 4.  Probiotics for preventing urinary tract infections in adults and children.

Authors:  Erin M Schwenger; Aaron M Tejani; Peter S Loewen
Journal:  Cochrane Database Syst Rev       Date:  2015-12-23

Review 5.  Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination.

Authors:  Baudouin Standaert; Rino Rappuoli
Journal:  J Mark Access Health Policy       Date:  2017-08-31

6.  Early recognition and response to increases in surgical site infections using optimized statistical process control charts-the Early 2RIS Trial: a multicenter cluster randomized controlled trial with stepped wedge design.

Authors:  Deverick J Anderson; Iulian Ilieş; Katherine Foy; Nicole Nehls; James C Benneyan; Yuliya Lokhnygina; Arthur W Baker
Journal:  Trials       Date:  2020-10-28       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.